About Alfriend & Team
Giving Back: Fight to Win
The Alfriend Group is committed to curing childhood cancer, one home at time. Giving back is an important part of our philosophy, and we believe that “Money is good for the good that it can do”. Therefore a portion of every commission we receive is donated towards funding specific pediatric cancer research and supporting families affected by childhood cancer.
These funds identify local children with specific needs in their fight with cancer. Funds assist families with uncovered medical expenses, travel and lodging expenses to other hospitals, needed improvements to make their homes safer and more comfortable, and other family costs related to treatments.
Funding wishes through The Make-A-Wish Foundation for local children with cancer, delivering “Stuff and Fluff” stuffed animals to every child at Nationwide Children’s every Christmas, installing new TV’s in every cancer room and partnering in building a teen cancer lounge at Nationwide Children’s, and other areas of need to help local children and teens with cancer.
The average pediatric cancer drug requires 15 years of research and over $1 billion. The result is that the majority of funding is directed only toward treatments involving highly profitable patented drugs. Other promising treatments are often ignored. Through CureSearch, the largest organization of pediatric oncologists, we identify promising research that is lacking funding.
PAC-2 (People Against Childhood Cancer) is a political action group that organizes an annual meeting in September between members of the U.S. Congress and professionals and foundations involved in pediatric cancer research. The sessions are created to bring more federal funding in the areas of greatest need in pediatric cancer research. Kyle Alfriend is one of the presenters, focusing specifically on adolescent and young adult cancers.
Fast Facts About Childhood Cancer:
- Cancer is the leading cause of death from disease in children.
- 1 in every 330 children will be diagnosed with cancer. That is 46 children, 2 classrooms full, each day.
- More children die from cancer than from all other childhood diseases combined.
- The incidence of childhood cancer has increased every year for the last 25 years.
- There are 12 major categories of cancers unique to children, covering 97 distinct types of cancers.
- All childhood cancers combined receive less that 3% of all cancer research funds. The reason is that childhood cancer treatments are far less profitable than adult cancer treatments.
- The cause of most childhood cancers is still unknown. They appear to be random, unaffected by lifestyle, heredity, or environment.
- Childhood cancer attacks quickly, without warning. At the time of initial diagnosis, the cancer has spread to other areas in 80% of children. This is compared to 20% on adult cancers.
- In the past 25 years, only three new pediatric cancer drugs have been approved by the FDA.
- Children can handle more chemo than adults. Due to the limited pediatric funding, most pediatric cancer treatments are simply mega doses of outdated adult chemotherapies created in the 1960’s and 1970’s.
- For reasons not fully understood, teenage cancer survivors experience the highest rates of secondary cancers, as well as liver, heart, and lung complications. And teenagers between ages 15-19 have the lowest survival rate of any age bracket under 75.
- Among these children, 20% die of the cancer itself, and an additional 14% die of related health issues. 25% live with disabling lifelong health concerns, and 19% with moderate health problems. Only 22% live a full and healthy life.
The “Fight To Win” Story:
In 2007, Tyler Alfriend was an athletic 15 year old at Dublin Jerome High School, active in basketball and track. During basketball season, he began having flu-like symptoms that doctors misdiagnosed as mono, strep, appendicitis, and then crohn’s disease. After three weeks of testing, doctors discovered a tumor in Tyler’s intestines. It was the size of three baseballs, stacked up like a snowman.
Tyler was diagnosed with sporadic Burkitt’s Lymphoma Leukemia, a rare and aggressive cancer that doubles every 12 hours. At the time of diagnosis, the tumors had already spread to his bladder, spleen, pancreas, kidneys, stomach, and liver. The following week it moved into his lungs and heart, and eventually to 85% of his bone marrow and central nervous system.
When Tyler was told the prognosis for survival was very grave, he responded to the doctors, “I will beat this. Because whenever I fight, I always fight to win.” He immediately began a yearlong process of experimental treatments, spinal taps, aggressive chemotherapies, and surgeries. The local community immediately surrounded Tyler with support and prayers. Area businesses held “Tyler’s Fight To Win” fundraisers. Students shaved their heads and wore “Tyler’s Fight to Win” t-shirts and wrist bands. On February 2nd Dublin schools held continuous sporting event fundraisers, from 7am to 11 pm. The Dublin city council proclaimed the day to be “henceforth and forever more known as Tyler Alfriend – Fight To Win Day” in the city of Dublin”. Other area schools, churches, and sports teams began having prayer meetings and events. Eventually letters of prayer support and requests for t-shirts and wristbands came from every state in the U.S. and 27 other countries.
Soon Tyler was receiving calls and visits from many of his hero’s, including Tony Dungy, Dwayne Wade, Jason Taylor, Wayne Greksky, Lance Armstrong, Chris Quinn, AJ Hawk, Brady Quinn, Archie Griffin, Dan Marino, Clint Eastwood, and others.
Today, Tyler is in excellent health, an active athlete, and a student at The Ohio State University. Tyler’s story was the result of three critical factors:
- The prayers of people around the world.
- The newest available research and treatments.
- The persistence of his family to find every possible option to save his life.
Tyler’s father, Kyle Alfriend, has maintained the extensive database of medical, research, pharmaceutical, and government contacts used to navigate through the complex bureaucratic world of experimental cancer treatments. The “Fight To Win” Foundation is dedicated to freely providing those resources to assist other families facing similar obstacles. The entire team at The Alfriend Group is committed our purpose: A career worth having, to fund a cause worth fighting and a life worth living.
Always fight to win.